PULMONARY EMBOLISM IN BREAST CANCER: ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT APPROACHES

Pulmonary embolism in breast cancer is one of the causes of major deterioration of health status of the patients. Pulmonary artery occlusion is most often a  consequence of venous thromboembolism; this condition is referred to as "pulmonary thromboembolism". Significantly less common cause of occlusion of the pulmonary artery branches can be embolism by a  cluster of tumor cells, accompanied by development of pulmonary tumor thrombotic microangiopathy. This paper reviews data on the etiology and pathogenesis of pulmonary embolism in breast cancer, and approaches to its prevention and treatment

The New Light Ion Injector for NICA

Within the upgrade scheme of the injection complex of the NICA project and after a successful beam commissioning of a heavy ion linac, Bevatech GmbH will build a first part of a new light ion linac as an injector for the Nuclotron ring. The linac will provide a beam of polarised protons and light ions with a mass to charge ratio up to 3 and an energy of 7 MeV/u. The mandate of the Linac does not only include the hardware for the accelerating structures, focusing magnets and beam diagnostic devices, but also the LLRF control soft- and hardware based on the MicroTCA.4 standard in collaboration with the MicroTCA Technology Lab at DESY. An overview of the Linac is presented in this paper